Rubin, Mark A.
University of Bern,
Switzerland
2025 Rank: 17694
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 515 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 17694 | 18687 |
| Total Cites | 5945 | 6397 |
| H-index | 38 | 40 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 52 | 54 |
| Number of Single+First+Last Authored Papers | 157 | 157 |
| Total Cites to Single+First+Last Authored Papers | 571 | 600 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4172 | 4366 |
| Ratio of Total Citations to Distinct Citing Papers | 1.42 | 1.47 |
| Self-Citation Percentage |
7.07%
|
|
Rubin, Mark A.
University Hospital Bern,
Switzerland
2024 Rank: 11813
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 379 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 11813 | 12428 |
| Total Cites | 6179 | 6760 |
| H-index | 40 | 41 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 11 | 11 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 61 | 65 |
| Number of Single+First+Last Authored Papers | 157 | 157 |
| Total Cites to Single+First+Last Authored Papers | 587 | 626 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4364 | 4619 |
| Ratio of Total Citations to Distinct Citing Papers | 1.42 | 1.46 |
| Self-Citation Percentage |
8.59%
|
|
Rubin, Mark A.
Weill Cornell Medicine,
United States
2023 Rank: 12367
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 446 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 12367 | 12746 |
| Total Cites | 7088 | 7768 |
| H-index | 42 | 43 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 38 | 38 |
| Total Cites to Single+First Authored Papers | 60 | 62 |
| Number of Single+First+Last Authored Papers | 158 | 158 |
| Total Cites to Single+First+Last Authored Papers | 735 | 800 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4835 | 5103 |
| Ratio of Total Citations to Distinct Citing Papers | 1.47 | 1.52 |
| Self-Citation Percentage |
8.75%
|
|
Rubin, Mark A.
University of Bern,
Switzerland
2022 Rank: 8112
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 311 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 8112 | 8165 |
| Total Cites | 9412 | 10533 |
| H-index | 47 | 51 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 7 | 7 |
| Number of Single+First Authored Papers | 38 | 38 |
| Total Cites to Single+First Authored Papers | 75 | 77 |
| Number of Single+First+Last Authored Papers | 158 | 158 |
| Total Cites to Single+First+Last Authored Papers | 806 | 866 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6332 | 6764 |
| Ratio of Total Citations to Distinct Citing Papers | 1.49 | 1.56 |
| Self-Citation Percentage |
10.64%
|
|
Rubin, Mark A.
Weill Cornell Medicine,
United States
2021 Rank: 7351
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 275 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 7351 | 7319 |
| Total Cites | 13433 | 15061 |
| H-index | 56 | 60 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 13 | 13 |
| Number of Single+First Authored Papers | 38 | 38 |
| Total Cites to Single+First Authored Papers | 132 | 139 |
| Number of Single+First+Last Authored Papers | 159 | 159 |
| Total Cites to Single+First+Last Authored Papers | 1236 | 1337 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8938 | 9633 |
| Ratio of Total Citations to Distinct Citing Papers | 1.50 | 1.56 |
| Self-Citation Percentage |
10.81%
|
|
Rubin, Mark A.
Weill Cornell Medicine,
United States
2020 Rank: 4709
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 155 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 4709 | 4423 |
| Total Cites | 9418 | 10746 |
| H-index | 49 | 52 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 20 | 21 |
| Number of Single+First Authored Papers | 39 | 39 |
| Total Cites to Single+First Authored Papers | 129 | 138 |
| Number of Single+First+Last Authored Papers | 159 | 159 |
| Total Cites to Single+First+Last Authored Papers | 1053 | 1180 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6167 | 6665 |
| Ratio of Total Citations to Distinct Citing Papers | 1.53 | 1.61 |
| Self-Citation Percentage |
12.36%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.